Artivion (AORT) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.37% |
| Dec 31, 2025 | -51.53% |
| Sep 30, 2025 | 18.49% |
| Jun 30, 2025 | -25.57% |
| Mar 31, 2025 | -20.96% |
| Dec 31, 2024 | 16.79% |
| Sep 30, 2024 | 20.47% |
| Jun 30, 2024 | 38.95% |
| Mar 31, 2024 | -41.38% |
| Dec 31, 2023 | -2.75% |
| Sep 30, 2023 | -13.20% |
| Jun 30, 2023 | 62.31% |
| Mar 31, 2023 | 10.72% |
| Dec 31, 2022 | 23.40% |
| Sep 30, 2022 | -4.75% |
| Jun 30, 2022 | -12.36% |
| Mar 31, 2022 | -30.04% |
| Dec 31, 2021 | -31.98% |
| Sep 30, 2021 | 12.31% |
| Jun 30, 2021 | -33.33% |
| Mar 31, 2021 | -22.93% |
| Dec 31, 2020 | 26.70% |
| Sep 30, 2020 | -78.08% |
| Jun 30, 2020 | 92.10% |
| Mar 31, 2020 | 103.08% |
| Dec 31, 2019 | -22.66% |
| Sep 30, 2019 | -32.88% |
| Jun 30, 2019 | 10.77% |
| Mar 31, 2019 | 21.08% |
| Dec 31, 2018 | -17.75% |
| Sep 30, 2018 | 7.74% |
| Jun 30, 2018 | -20.81% |
| Mar 31, 2018 | -25.82% |
| Dec 31, 2017 | -36.21% |
| Sep 30, 2017 | -16.94% |
| Jun 30, 2017 | 18.00% |
| Mar 31, 2017 | 41.84% |
| Dec 31, 2016 | -44.75% |
| Sep 30, 2016 | 42.22% |
| Jun 30, 2016 | 16.36% |
| Mar 31, 2016 | 28.58% |
| Dec 31, 2015 | -17.60% |
| Sep 30, 2015 | 22.23% |